Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157209
Status:
COMPLETED
Last Update Posted:
2015-11-18
First Post:
2005-09-08
Brief Title:
Phase 2b Randomized Controlled Study of Tecemotide L-BLP25 for Immunotherapy of NSCLC Non-Small Cell Lung Cancer
Sponsor:
Organization:
Merck KGaA Darmstadt Germany